Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://finance.yahoo.com/news/praxis-precision-medicines-announces-topline-123000869.html
0
0
Praxis Precision Medicines Announces Topline Results from the Essential1 Study of Ulixacaltamide for the Treatment of Essential Tremor and Continued Advancement of Program to Phase 3 - Yahoo Finance
+ 85 more
3/3/23 at 12:30pm
Organization
Yahoo Entertainment
Authors
Praxis Precision Medicines
Inc.
Details
55 words
Summarize
Business & Industrial
Health
Praxis Precision Medicines Announces Topline Results
Essential1 Study of Ulixacaltamide for the Treatment of Essential Tremor
Continued Advancement of Program
Yahoo Finance Based
Praxis
FDA
Based upon observed efficacy and safety profile, Praxis intends to engage with the FDA in an end of Phase 2 meeting and initiate a ulixacaltamide Phase 3...
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...